Literature DB >> 8234260

Phospholipase D-catalyzed hydrolysis of phosphatidylcholine provides the choline precursor for acetylcholine synthesis in a human neuronal cell line.

H C Lee1, M P Fellenz-Maloney, M Liscovitch, J K Blusztajn.   

Abstract

To identify the metabolic pathway that generates choline (Cho) for acetylcholine (AcCho) from its storage pool in membrane phosphatidylcholine (PtdCho), human neuronal cells (LA-N-2) were radioisotopically labeled with 1-O-hexadecyl-2-hydroxy-sn-glycero(3)phospho[14C]choline. The compound was efficiently taken up by the cells and metabolically labelled PtdCho, Cho, AcCho, and phosphocholine pools. In pulse-chase experiments, the specific radioactivities of the metabolites of 1-O-hexadecyl-2-hydroxy-sn-glycero(3)-phospho[14C]choline indicated that it was rapidly acylated to Ptd-Cho and then hydrolyzed first to free Cho and not to phosphocholine or glycerophosphocholine. This Cho was subsequently converted to AcCho and to phosphocholine. In the absence of exogenous Cho, at least 15% of the total cellular AcCho pool was synthesized by this pathway in 1 h. The data demonstrate that the liberation of the free Cho precursor for AcCho synthesis from PtdCho can be accomplished in a one-step process, indicating the involvement of a phospholipase D-type enzyme. In the presence of hemicholinium-3, which inhibits Cho transport, the amount of intracellular [14C]Cho metabolites that accumulated during the chase period was higher than in control cells, indicating that PtdCho hydrolysis liberated Cho directly into the cytoplasm. These data show that cholinergic cells are characterized by an intracellular pathway, catalyzed by a phospholipase D, that generates Cho for AcCho synthesis from PtdCho. Abnormalities in the regulation of this pathway may contribute to selective vulnerability of cholinergic neurons in certain neurodegenerative diseases, e.g., Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8234260      PMCID: PMC47718          DOI: 10.1073/pnas.90.21.10086

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  Signal-dependent activation of phosphatidylcholine hydrolysis: role of phospholipase D.

Authors:  M Liscovitch
Journal:  Biochem Soc Trans       Date:  1991-04       Impact factor: 5.407

2.  Changes of the phosphatidylcholine content and the number of synaptic vesicles in relation to the neurohumoral transmission in sympathetic ganglia.

Authors:  A Párducz; Z Kiss; F Joó
Journal:  Experientia       Date:  1976-12-15

3.  Substrate specificity of neutral phospholipase D from rat brain studied by selective labeling of endogenous synaptic membrane phospholipids in vitro.

Authors:  H Möhn; V Chalifa; M Liscovitch
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

4.  Formation of synaptic vesicles in the superior cervical ganglion of cat: choline dependency.

Authors:  A Parducz; F Joó; J Toldi
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

5.  Phospholipase D activity and phosphatidylethanol formation in stimulated HeLa cells expressing the human m1 muscarinic acetylcholine receptor gene.

Authors:  S Pepitoni; R G Mallon; J K Pai; J A Borkowski; M A Buck; R D McQuade
Journal:  Biochem Biophys Res Commun       Date:  1991-04-15       Impact factor: 3.575

6.  Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients.

Authors:  J K Blusztajn; I Lopez Gonzalez-Coviella; M Logue; J H Growdon; R J Wurtman
Journal:  Brain Res       Date:  1990-12-17       Impact factor: 3.252

7.  Phorbol esters modulate phospholipid metabolism in a human cholinergic cell line, LA-N-2: a possible role for the base exchange enzymes.

Authors:  I N Singh; D G McCartney; G Sorrentino; R Massarelli; J N Kanfer
Journal:  J Neurosci Res       Date:  1992-08       Impact factor: 4.164

8.  Metabolic conversion of platelet-activating factor into ethanolamine plasmalogen in an amnion-derived cell line.

Authors:  R A Frenkel; J M Johnston
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

9.  Synthesis of acetylcholine from choline derived from phosphatidylcholine in a human neuronal cell line.

Authors:  J K Blusztajn; M Liscovitch; U I Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

10.  Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease.

Authors:  J W Pettegrew; K Panchalingam; J Moossy; J Martinez; G Rao; F Boller
Journal:  Arch Neurol       Date:  1988-10
View more
  15 in total

Review 1.  Phospholipase D: molecular and cell biology of a novel gene family.

Authors:  M Liscovitch; M Czarny; G Fiucci; X Tang
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

2.  Sexually dimorphic activation of liver and brain phosphatidylethanolamine N-methyltransferase by dietary choline deficiency.

Authors:  P I Johnson; J K Blusztajn
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

3.  Region-specific and calcium-dependent increase in dialysate choline levels by NMDA.

Authors:  A Zapata; J L Capdevila; R Trullas
Journal:  J Neurosci       Date:  1998-05-15       Impact factor: 6.167

4.  Protective effects of 7,8-dihydroxyflavone on neuropathological and neurochemical changes in a mouse model of Alzheimer's disease.

Authors:  Nurgul Aytan; Ji-Kyung Choi; Isabel Carreras; Leah Crabtree; Brian Nguyen; Margaret Lehar; Jan Krzysztof Blusztajn; Bruce G Jenkins; Alpaslan Dedeoglu
Journal:  Eur J Pharmacol       Date:  2018-03-03       Impact factor: 4.432

Review 5.  The cholinergic neuronal phenotype in Alzheimer's disease.

Authors:  J K Blusztajn; B Berse
Journal:  Metab Brain Dis       Date:  2000-03       Impact factor: 3.584

6.  Apolipoprotein E in the brain and its role in Alzheimer's disease.

Authors:  J Poirier
Journal:  J Psychiatry Neurosci       Date:  1996-03       Impact factor: 6.186

7.  Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice.

Authors:  Shawn M Ferguson; Mihaela Bazalakova; Valentina Savchenko; Juan Carlos Tapia; Jane Wright; Randy D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-01       Impact factor: 11.205

Review 8.  Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics.

Authors:  K Janes; A M Symons-Liguori; K A Jacobson; D Salvemini
Journal:  Br J Pharmacol       Date:  2016-03-06       Impact factor: 8.739

9.  A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.

Authors:  Kali Janes; Emanuela Esposito; Timothy Doyle; Salvatore Cuzzocrea; Dillip K Tosh; Kenneth A Jacobson; Daniela Salvemini
Journal:  Pain       Date:  2014-09-19       Impact factor: 6.961

10.  Platelet phospholipase A2 activity in patients with Alzheimer's disease, vascular dementia and ischemic stroke.

Authors:  E Krzystanek; M Krzystanek; G Opala; H I Trzeciak; J Siuda; A Małecki
Journal:  J Neural Transm (Vienna)       Date:  2007-04-20       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.